We think SPH is in a good financial position. In the past three years, its debt over capital has been stable at around 0.4 times. Despite not being in a net cash position, it has enough cash to ...

How innovation, advanced manufacturing, and expertise drive success in the evolving CDMO and generics landscape.

CDMOs are shaping the future of fill-finish manufacturing.

We forecast WuXi's revenue growth to be slower than that of other well-established peers. The risk is high that the US Biosecure Act will become law, and we expect global pharmaceutical or ...

Kneat's SaaS model automates validation processes in pharma and biotech, reducing errors and ensuring compliance. Learn why ...

The global pharmaceutical company Teva announced a strategic partnership with Kerry Pharma, a subsidiary of the Kerry ...

The company has filed a Drug Master File (DMF) with the U.S. Food and Drug Administration (FDA) — a critical regulatory step. This product is now ready to be converted into a finished drug product.

The pharmaceutical industry relies heavily on advanced pharmaceutical machinery to ensure the highest standards of safety, efficiency, and precision. As a trusted pharmaceutical machinery manufacturer ...

Is this something that those in the manufacturing industry should be genuinely concerned about? Or are those in the industry simply looking at things through the wrong lens? While employees have every ...

West Pharmaceutical's strong GLP-1 and biologics segment positions it for growth. Click here to read why WST stock is upgraded to a Buy.

Hugh Tyrrell is the director of GreenEdge, a marketing communications and business development consultancy specialising in the circular economy. GOVERNMENT policy changes can often open ...